<?xml version="1.0" encoding="UTF-8"?>
<ref id="B83-viruses-12-01058">
 <label>83.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <name>
    <surname>Wire</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Chinaâ€™s Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.businesswire.com/news/home/20200305005764/en/China%E2%80%99s-Institute-Materia-Medica-Partners-Cyclica-Innovative" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.businesswire.com/news/home/20200305005764/en/China%E2%80%99s-Institute-Materia-Medica-Partners-Cyclica-Innovative</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-03-20">(accessed on 20 March 2020)</date-in-citation>
 </element-citation>
</ref>
